1601 E GEER ST STE S SUITE S DURHAM, NC 27704 Get Directions
1601 E GEER ST STE S SUITE S DURHAM, NC 27704 Get Directions
Xenobiotic Detection Systems (XDS) was started in 1995 by Drs. George C. Clark and Michael S. Denison. In 1997 XDS received major Research and Development funding from the National Institutes of Health for their dioxin analysis bioassay and their endocrine disruptor assay as well.
In 1998 XDS was awarded a U.S. patent (5,854,010) for its proprietary XDS-CALUX(R) (Chemically-Activated LUciferase gene eXpression cell bioassay system) assay for dioxin-like chemicals.
In 2004 XDS was awarded a U.S. patent (6,720,431 B2) for their novel method of separation of dioxins/furans and dioxin-like PCB's for XDS-CALUX(R) analysis.
In July 2006, the LUMI-CELL(R) ER bioassay system completed ICCVAM's protocol standardization study, also know as the U.S. pre-validation study.
In March of 2007 the LUMI-CELL(R) ER bioassay system started the international validation study with ICCVAM, ECVAM, and JaCVAM.
In 2007, the EPA's Office of Solid Waste (OSW) Organic Methods Workgroup formally reviewed and approved the XDS-CALUX(R) technology (EPA Method #4435) for inclusion into Test Methods for Evaluating Solid Waste, Physical/Chemical Methods, also known as SW-846.
© Dun & Bradstreet, Inc. 2025. All rights reserved.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.